Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-22

Clinical Trial Update: Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC [Phase 3]

View source ↗

Summary

Phase 3 non-inferiority trial comparing standard radiotherapy to hypofractionated split course in elderly vulnerable patients with head and neck squamous cell c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Groupe Oncologie Radiotherapie Tete et Cou | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 3 | Status: COMPLETED